Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|October 11, 2019
CLINICAL CHARACTERISTICS OF PRIMARY EXTRANODAL VERSUS NODAL DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE COHORT STUDY IN A CANCER CENTERMyrna Candelaria, Luis F Oñate-Ocaña, Judith Corona-Herrera, et al.BMC Women'S Health|February 9, 2006
Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year resultsLucely Cetina, Lesbia Rivera, José Hinojosa, et al.American Journal of Cancer Research|July 15, 2024
The inhibitory and transcriptional effects of the epigenetic repurposed drugs hydralazine and valproate in lymphoma cellsHarold Salamanca-Ortiz, Guadalupe Domínguez-Gomez, Alma Chávez-Blanco, et al.Oncology Letters|July 17, 2018
Metabolic tumor volume changes assessed by interval 18fluorodeoxyglucose positron emission tomography-computed tomography for the prediction of complete response and survival in patients with diffuse large B-cell lymphomaLuis F Oñate-Ocaña, Violeta Cortés, Rodrigo Castillo-Llanos, et al.The Journal of Obstetrics and Gynaecology Research|February 23, 2012
Adenocarcinoma metastatic to the uterine cervix: a case seriesDelia Pérez-Montiel, Alberto Serrano-Olvera, Luz Calderón Salazar, et al.BMC Cancer|September 21, 2005
Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancerCarlos Lopez-Graniel, Rigoberto Dolores, Lucely Cetina, et al.Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|May 27, 2021
A Cohort Study of the Prognostic Impact of Exon-16 EZH2 Mutations in a Mexican-Mestizo Population of Patients with Diffuse Large B-Cell LymphomaLuis F Oñate-Ocaña, Mayra Ponce-Martínez, Lucia Taja-Chayeb, et al.Medical Oncology (Northwood, London, England)|October 1, 2004
Ocular metastases from breast carcinomaAlberto Mejía-Novelo, Alberto Alvarado-Miranda, Flavia Morales-Vázquez, et al.Medical Oncology (Northwood, London, England)|March 8, 2005
Her-2/neu expression as a predictive factor for response to anthracycline-based chemotherapy in a mexican population of locally advanced breast cancer patientsDavid Muñoz-Gonzalez, Isabel Zeichner-Gancz, Myrna Candelaria, et al.Frontiers in Cell and Developmental Biology|December 27, 2021
Regulation of miRNAs Expression by Mutant p53 Gain of Function in CancerTzitzijanik Madrigal, Jesús Hernández-Monge, Luis A Herrera, et al.Pageof 8